pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4753 |
Genomic Coordinates | chr1: 235190034 - 235190116 |
Description | Homo sapiens miR-4753 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4753-5p | |||||||||||||||||||||
Sequence | 10| CAAGGCCAAAGGAAGAGAACAG |31 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ADIPOR2 | ||||||||||||||||||||
Synonyms | ACDCR2, PAQR2 | ||||||||||||||||||||
Description | adiponectin receptor 2 | ||||||||||||||||||||
Transcript | NM_024551 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ADIPOR2 | |||||||||||||||||||||
3'UTR of ADIPOR2 (miRNA target sites are highlighted) |
>ADIPOR2|NM_024551|3'UTR 1 TACCTACCAGTCTCCAGGGACTATGACCCTAAACCAGGGCCTGCGGCACTTGCGGGCCTCCCTGCTGGCTACTGATGCCA 81 GTACCAGAGGAGCCCCAAAACTTTGACAGCCTCGTGGGCTTTGTGACGGCCCAGGGGCTCTGCGTGGTACATGACTGAGA 161 AGAGAAAAACAAAAATAAATCATACCTCAAAGGATGGAGTGCATCAATTGGGAGAAAAGGAGACATAGCCCAAACCCTGG 241 CTTATTCTTGGGATCTACTGATTGCGGGCTCTGCAAGACCCTTGGCAAACTGGCTTCTGATCCATATCATATTTATTTGT 321 AGAAGATGGCGAAACAGTTTAGCTGGTGGTTCTTTCTTCTCCCTTTCTCTCTCTCTATGACAATAATACAAACCAATTTA 401 AGTGAACATTTATATCCGATAAGGGGTGGGAGTGTGATTTTAAATGCTCTTTTGGGAGAACAAAGAAATTAATGTAAATA 481 AGATTTCTAACTGTTTAAATAAGACTTTATATAAATGTTTAAAACATAGGGGTAAGGGAGGGAGGGAGAATTTTTGTATA 561 GAATGAAACATGCAAGTACCACACACTGTTTGAATTTTGCACAAAAAGTGACTGTAGGATCAGGTGATAGCCCCGGAATG 641 TACAGTGTCTTGGTGCACCAAGATGCCTTCTAAAGGCTGACATACCTTGGACCCTAATGGGGCAGAGAGTATAGCCCTAG 721 CCCAGTGGTGACATGACCACTCCCTTTGGGAGGCCTGAGGTAGAGGGGAGTGGTATGTGTTTTCTCAGTGGAAGCAGCAC 801 ATGAGTGGGTGACAGGATGTTAGATAAAGGCTCTAGTTAGGGTGTCATTGTCATTTGAGAGACTGACACACTCCTAGCAG 881 CTGGTAAAGGGGTGCTGGAGGCCATGGAGGAGCTCTAGAAACATTAGCATGGGCTGATCTGATTACTTCCTGGCATCCCG 961 CTCACTTTTATGGGAAGTCTTATTAGAGGGATGGGACAGTTTTCCATATCCTTGCTGTGGAGCTCTGGAACACTCTCTAA 1041 ATTTCCCTCTATTAAAAATCACTGCCCTAACTACACTTCCTCCTTGAGGGAATAGAAATGGACCTTTCTCTGACATAGTT 1121 CTTGGCATGGGAGCCAGCCACAAATGAGATTCTGACGTGTCCAGGTTTCTCCTGAGCTCATCTACATAGATTGGTAGACC 1201 CTTCCTTTGGATTAGGAAAGATGAGTTTTACCTCTGGTACACTGTCTTGGTAAGCCTGGATGTGACAGACACCTCGGCTC 1281 TCCTTGAATAAGAAAGCCAGCAGAACTCTTAAAGCCAGTTGTAGTACGGAGTTGTCAGCACTCACTGAACCTCACTTTAC 1361 AGGGATAAGAGTGGTGTGGCATTTTAAATACAATGGTATGTTATTGCCAGGGAGTGAGGTACAAGACGATGGCTCATGTC 1441 ACAGGCCTACCTGATACGGTGTCAGAGAAAGTGGTGGGGAAAGGATCTGGTTCATGGAATTCTGATCTTGGCCCATAGGT 1521 GAACCACCAAAATAGTGCTCGAGTCTTAGGTTACTGTCATCAAAGACTTGGGATGACTCCATTATATCCTGGGGTTGTGG 1601 GTATTAGAACTAAATATGGAGGTCCTGAGCATGGGGACTGGCGTCCTCAGTAGGTGTTTGGGAATATGGGAAGGGTCTCC 1681 TATTTATTCAATAGAGTTTTCTCAGTTATTTTCCTCCCTTGCCCTTGCAATCTCCAGCAAAAGGTGGGATCTAGGAAGAA 1761 AGAATCCAGTGTAGAAGTTGAGAAGAACTTGAACGTTTTGGTTCTGGATAAGGTCACTGTCCTAGGTGCTAGGTGGACCG 1841 AGCAAAAGACTCAGTGGATGAACTGGTGCAGTGCCTGACAGAATAAAGAACAGTATTAATCCCTTTGAGAAAGCATAGTC 1921 CAGCAGGACAGTGGCCATTTGGACAGAAGCCCACTTAGTTTCTTGGGAGCAACAGCACGTATCAGAAGCCAGACTTGCTC 2001 TTCGGTCATGCACTTTGGGATACAGCGTATAGGTGCAGCCCTGTCACAACACCAACAGAAGTAGCAGCCTCTGGGTGCAG 2081 TCACCCACACCCCAAAGCTGGAAGGATCTGGTTCAACATAGCACAAACCCTTAGGAAAAATGAAATTAACATCACTGATG 2161 TGTAATCCAGTAAAATCTCCCTTTTTCGGGTGTGTATGTGGGCATGTGCCCATTTCTATGTGTGTGTCTACGTGCAGCTC 2241 ACTACCAACAGCCTCATGTGCACTTGACCTGACAGTGCTCGCTGAGAACTCTCACCAGGTTGGCGCCTGAATGCCTTACT 2321 CTCAGCAGTCAGAGGCTTGCTTGCTCTGTGCAGATTTTTAATTTTCTTTTTTGGCCCTAGGCTGGTTGGGACCTCTACAG 2401 CTTCATTCTTTCACCATTAAATAGTGGCCTTTTTCAGTATTTTCCCTCTTCCCCTTTATAAATTATGCTAAAGCCACAAA 2481 GCACATTTTTGGGGATCATAGAAGGTTGGGGTTCCAGAAAGGCATCTGTGTGATGGTTCCATTGATGTGGGATTTCCCTA 2561 CTTGCTGTATTCTCAGTTTCTAATAAAAAGAACCAAATGAAATATGAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
CLIP-seq Support 1 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000357103.4 | 3UTR | CUUCAUUCUUUCACCAUUAAAUAGUGGCCUUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
94 hsa-miR-4753-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT064916 | ZBTB18 | zinc finger and BTB domain containing 18 | 2 | 2 | ||||||||
MIRT161166 | SLC25A36 | solute carrier family 25 member 36 | 2 | 2 | ||||||||
MIRT285542 | CDT1 | chromatin licensing and DNA replication factor 1 | 2 | 2 | ||||||||
MIRT308266 | LRIG1 | leucine rich repeats and immunoglobulin like domains 1 | 2 | 2 | ||||||||
MIRT311425 | LMNB1 | lamin B1 | 2 | 2 | ||||||||
MIRT373989 | PEBP1 | phosphatidylethanolamine binding protein 1 | 2 | 4 | ||||||||
MIRT383141 | CRY2 | cryptochrome circadian clock 2 | 2 | 2 | ||||||||
MIRT405243 | ADIPOR2 | adiponectin receptor 2 | 2 | 2 | ||||||||
MIRT441620 | ROCK1 | Rho associated coiled-coil containing protein kinase 1 | 2 | 6 | ||||||||
MIRT441789 | SRPK1 | SRSF protein kinase 1 | 2 | 2 | ||||||||
MIRT441804 | NOC3L | NOC3 like DNA replication regulator | 2 | 2 | ||||||||
MIRT441832 | ALG14 | ALG14, UDP-N-acetylglucosaminyltransferase subunit | 2 | 2 | ||||||||
MIRT442005 | NDUFV3 | NADH:ubiquinone oxidoreductase subunit V3 | 2 | 2 | ||||||||
MIRT442411 | LIMD1 | LIM domains containing 1 | 2 | 2 | ||||||||
MIRT442708 | UBE4B | ubiquitination factor E4B | 2 | 2 | ||||||||
MIRT442714 | TNRC6B | trinucleotide repeat containing 6B | 2 | 2 | ||||||||
MIRT442738 | SERINC5 | serine incorporator 5 | 2 | 2 | ||||||||
MIRT442793 | CEP170 | centrosomal protein 170 | 2 | 2 | ||||||||
MIRT442984 | ZNF736 | zinc finger protein 736 | 2 | 2 | ||||||||
MIRT443055 | THRB | thyroid hormone receptor beta | 2 | 2 | ||||||||
MIRT443288 | ZC3H12A | zinc finger CCCH-type containing 12A | 2 | 2 | ||||||||
MIRT443325 | SLC35G1 | solute carrier family 35 member G1 | 2 | 2 | ||||||||
MIRT443331 | OCRL | OCRL, inositol polyphosphate-5-phosphatase | 2 | 2 | ||||||||
MIRT443593 | ZNF439 | zinc finger protein 439 | 2 | 4 | ||||||||
MIRT443696 | KCNN3 | potassium calcium-activated channel subfamily N member 3 | 2 | 2 | ||||||||
MIRT443748 | ELL2 | elongation factor for RNA polymerase II 2 | 2 | 2 | ||||||||
MIRT443866 | HDLBP | high density lipoprotein binding protein | 2 | 2 | ||||||||
MIRT461185 | LTBP2 | latent transforming growth factor beta binding protein 2 | 2 | 2 | ||||||||
MIRT464074 | WAC | WW domain containing adaptor with coiled-coil | 2 | 2 | ||||||||
MIRT468738 | SDC4 | syndecan 4 | 2 | 2 | ||||||||
MIRT470540 | COASY | Coenzyme A synthase | 2 | 2 | ||||||||
MIRT476458 | GBA2 | glucosylceramidase beta 2 | 2 | 2 | ||||||||
MIRT479470 | CDK6 | cyclin dependent kinase 6 | 2 | 2 | ||||||||
MIRT486351 | TACC2 | transforming acidic coiled-coil containing protein 2 | 2 | 8 | ||||||||
MIRT495126 | CXorf67 | chromosome X open reading frame 67 | 2 | 2 | ||||||||
MIRT495166 | CNGA2 | cyclic nucleotide gated channel alpha 2 | 2 | 4 | ||||||||
MIRT495432 | ATG7 | autophagy related 7 | 2 | 2 | ||||||||
MIRT495922 | FBXO41 | F-box protein 41 | 2 | 2 | ||||||||
MIRT496572 | DGCR6L | DiGeorge syndrome critical region gene 6 like | 2 | 2 | ||||||||
MIRT498277 | POFUT1 | protein O-fucosyltransferase 1 | 2 | 2 | ||||||||
MIRT498431 | DDX39A | DExD-box helicase 39A | 2 | 2 | ||||||||
MIRT530149 | HADHB | hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit | 2 | 2 | ||||||||
MIRT530313 | TNFRSF10D | TNF receptor superfamily member 10d | 2 | 2 | ||||||||
MIRT530880 | TRUB1 | TruB pseudouridine synthase family member 1 | 2 | 4 | ||||||||
MIRT531177 | ZNF626 | zinc finger protein 626 | 2 | 2 | ||||||||
MIRT533395 | TYRP1 | tyrosinase related protein 1 | 2 | 2 | ||||||||
MIRT533709 | TMEM64 | transmembrane protein 64 | 2 | 2 | ||||||||
MIRT533954 | TAF1D | TATA-box binding protein associated factor, RNA polymerase I subunit D | 2 | 2 | ||||||||
MIRT535616 | NSD1 | nuclear receptor binding SET domain protein 1 | 2 | 2 | ||||||||
MIRT539472 | ADARB2 | adenosine deaminase, RNA specific B2 (inactive) | 2 | 2 | ||||||||
MIRT542878 | NR6A1 | nuclear receptor subfamily 6 group A member 1 | 2 | 2 | ||||||||
MIRT559077 | C19orf47 | chromosome 19 open reading frame 47 | 2 | 2 | ||||||||
MIRT559465 | ARPP19 | cAMP regulated phosphoprotein 19 | 2 | 2 | ||||||||
MIRT561233 | ZNF772 | zinc finger protein 772 | 2 | 2 | ||||||||
MIRT563477 | POLE3 | DNA polymerase epsilon 3, accessory subunit | 2 | 2 | ||||||||
MIRT563995 | SLFN11 | schlafen family member 11 | 2 | 2 | ||||||||
MIRT564222 | SDE2 | SDE2 telomere maintenance homolog | 2 | 2 | ||||||||
MIRT566017 | RHOA | ras homolog family member A | 2 | 2 | ||||||||
MIRT566028 | RFX1 | regulatory factor X1 | 2 | 2 | ||||||||
MIRT566591 | NUFIP2 | NUFIP2, FMR1 interacting protein 2 | 2 | 2 | ||||||||
MIRT567874 | CTDSP1 | CTD small phosphatase 1 | 2 | 2 | ||||||||
MIRT568552 | AKT2 | AKT serine/threonine kinase 2 | 2 | 2 | ||||||||
MIRT569357 | EFHC1 | EF-hand domain containing 1 | 2 | 2 | ||||||||
MIRT569973 | DNAAF2 | dynein axonemal assembly factor 2 | 2 | 2 | ||||||||
MIRT614423 | ZNF440 | zinc finger protein 440 | 2 | 2 | ||||||||
MIRT628831 | SLC25A34 | solute carrier family 25 member 34 | 2 | 2 | ||||||||
MIRT630142 | ZFYVE9 | zinc finger FYVE-type containing 9 | 2 | 2 | ||||||||
MIRT634479 | PAFAH1B2 | platelet activating factor acetylhydrolase 1b catalytic subunit 2 | 2 | 2 | ||||||||
MIRT634498 | OR7D2 | olfactory receptor family 7 subfamily D member 2 | 2 | 2 | ||||||||
MIRT637394 | R3HDM2 | R3H domain containing 2 | 2 | 2 | ||||||||
MIRT641840 | TCF7L2 | transcription factor 7 like 2 | 2 | 2 | ||||||||
MIRT644397 | CDKL1 | cyclin dependent kinase like 1 | 2 | 2 | ||||||||
MIRT644888 | C2orf50 | chromosome 2 open reading frame 50 | 2 | 2 | ||||||||
MIRT647124 | ZNF446 | zinc finger protein 446 | 2 | 2 | ||||||||
MIRT647420 | SSTR3 | somatostatin receptor 3 | 2 | 2 | ||||||||
MIRT650297 | PYCARD | PYD and CARD domain containing | 2 | 2 | ||||||||
MIRT655488 | PAK3 | p21 (RAC1) activated kinase 3 | 2 | 2 | ||||||||
MIRT658185 | FBXO9 | F-box protein 9 | 2 | 2 | ||||||||
MIRT660931 | ADAM19 | ADAM metallopeptidase domain 19 | 2 | 2 | ||||||||
MIRT665317 | ZBTB3 | zinc finger and BTB domain containing 3 | 2 | 2 | ||||||||
MIRT670350 | C1orf106 | chromosome 1 open reading frame 106 | 2 | 4 | ||||||||
MIRT670823 | NICN1 | nicolin 1 | 2 | 2 | ||||||||
MIRT671825 | TRPM6 | transient receptor potential cation channel subfamily M member 6 | 2 | 2 | ||||||||
MIRT672732 | NETO2 | neuropilin and tolloid like 2 | 2 | 2 | ||||||||
MIRT674841 | GLRX2 | glutaredoxin 2 | 2 | 2 | ||||||||
MIRT675930 | CYP51A1 | cytochrome P450 family 51 subfamily A member 1 | 2 | 2 | ||||||||
MIRT686786 | AZF1 | azoospermia factor 1 | 2 | 2 | ||||||||
MIRT697723 | USP8 | ubiquitin specific peptidase 8 | 2 | 2 | ||||||||
MIRT702357 | KLHL26 | kelch like family member 26 | 2 | 2 | ||||||||
MIRT704361 | DBR1 | debranching RNA lariats 1 | 2 | 2 | ||||||||
MIRT709242 | RANGAP1 | Ran GTPase activating protein 1 | 2 | 2 | ||||||||
MIRT714433 | SNED1 | sushi, nidogen and EGF like domains 1 | 2 | 2 | ||||||||
MIRT717000 | ARL6IP4 | ADP ribosylation factor like GTPase 6 interacting protein 4 | 2 | 2 | ||||||||
MIRT720875 | ADCY5 | adenylate cyclase 5 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|